Siemens Healthineers AG (SMMNY)
| Market Cap | 54.04B |
| Revenue (ttm) | 27.43B |
| Net Income (ttm) | 2.52B |
| Shares Out | n/a |
| EPS (ttm) | 2.24 |
| PE Ratio | 21.48 |
| Forward PE | 17.61 |
| Dividend | 0.30 (1.22%) |
| Ex-Dividend Date | Feb 20, 2025 |
| Volume | 150,800 |
| Average Volume | 89,776 |
| Open | 24.18 |
| Previous Close | 24.05 |
| Day's Range | 24.14 - 24.35 |
| 52-Week Range | 23.28 - 30.19 |
| Beta | 0.85 |
| RSI | 33.82 |
| Earnings Date | Nov 5, 2025 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2025, Siemens Healthineers AG's revenue was 23.38 billion, an increase of 4.53% compared to the previous year's 22.36 billion. Earnings were 2.14 billion, an increase of 10.40%.
Financial numbers in EUR Financial StatementsNews
Siemens Healthineers AG (SMMNY) Analyst/Investor Day - Slideshow
2025-11-19. The following slide deck was published by Siemens Healthineers AG in conjunction with this event.
Siemens Healthineers AG (SMMNY) Analyst/Investor Day Transcript
Siemens Healthineers: Healthcare Remains Attractive After 2025
Siemens Plans to Reduce Stake in Siemens Healthineers to Focus on Core Businesses
Siemens Plans to Reduce Stake in Siemens Healthineers to Focus on Core Businesses
Siemens targets 6–9% mid-term revenue growth; expands market outlook to €650 billion
Siemens is aiming for a mid-term revenue growth rate of 6–9%, excluding Siemens Healthineers, CEO Roland Busch said during an...
Siemens To Deconsolidate Majority Stake In Siemens Healthineers
(RTTNews) - Siemens AG announced its decision to deconsolidate its remaining approximately 67% stake in Siemens Healthineers. This strategic move, approved today by both the Managing Board and the Sup...
Siemens to Hand €15 Billion Stake in MRI Maker to Investors
Siemens AG will hand a 30% stake in Siemens Healthineers AG to its own shareholders, allowing it to reduce its exposure to the medical technology business and focus on software.
Siemens reportedly eyeing a direct spinoff of Healthineers stake
Siemens (SIEGY) stock is in focus as the company plans a direct spinoff of its Siemens Healthineers (SMMNY) unit. Read more here.
Siemens Healthineers preparing for potential Siemens's share sale -CFO
Siemens Healthineers is preparing for the possibility that its biggest shareholder Siemens AG may reduce its stake in the medical technology company to less than 50%, its CFO said on Wednesday.
Siemens Healthineers AG (SMMNY) Q4 2025 Press Conference Call Transcript
Q4 2025 Siemens Healthineers AG Earnings Call Transcript
Q4 2025 Siemens Healthineers AG Earnings Call Transcript
Siemens Healthineers AG (SMMNY) Q4 2025 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SMMNY) Q4 2025 Earnings Call November 5, 2025 2:00 AM ESTCompany ParticipantsMarc Koebernick - Head of Investor...
Siemens Healthineers Shares Slump After Tariffs Hit Profit
Siemens Healthineers AG 2025 Q4 - Results - Earnings Call Presentation
2025-11-05. The following slide deck was published by Siemens Healthineers AG in conjunction with their 2025 Q4 earnings call.
Siemens Healthineers reports Q4 results
Siemens Healthineers posts strong Q4 with rising EBIT margin, higher cash flow, and increased dividend.
Siemens Healthineers Q4 Profit Down, Lifts Dividend; Issues FY26 Outlook
(RTTNews) - Siemens Healthineers AG (SMMNY.PK) reported Wednesday lower profit in its fourth quarter with slightly lower revenues. Further, the company proposed higher dividend, and issued fiscal 2026...
Siemens Healthineers slightly misses sales expectations in fourth quarter
Siemens Healthineers on Wednesday reported fourth-quarter revenue slightly below analysts' consensus as higher U.S. import tariffs weigh.
Siemens evaluating spinoff of stake in Siemens Healthineers - report
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #drugtesting--New drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
Siemens Healthineers AG (SMMNY) Pre-Close For Q4 FY2025 (Transcript)
Siemens Healthineers AG - Special Call
Siemens Healthineers AG - Special Call Company Participants Presentation Unknown Executive Welcome to our pre-close catch-up for Q4 fiscal year 2025, which was recorded on September 25, 2025. In this ...
European Stocks Open Lower; H&M Surges, Siemens Healthineers (SHL) Falls
European Stocks Open Lower; H&M Surges, Siemens Healthineers (SHL) Falls
VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million
SAN DIEGO--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a Series A extension alongside a strategic agreement with Siemens Healthineers...
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Deal Dispatch: White House Mute On TikTok, BBVA's $18 Billion Takeover Offer Rejected
New On The Block Siemens Healthineers is chatting with major private equity firms about a potential sale of its diagnostics business. According to Bloomberg, Blackstone , CVC , KKR , and Montagu are i...